Abstract: The invention is a cooling unit for a heat exchanger integrated in an oxygenator for the purpose of controlling the temperature of blood conveyed in an extracorporeal blood circuit. The cooling unit has a reservoir in which a liquid is stored, a reaction vessel comprises a reactant and which, in conjunction with the liquid, is able to initiate an endothermal reaction. A fluidic access is generated between the reservoir and the reaction vessel. A fluid line extends at least in part inside the reaction vessel which has an inlet line and outlet line connected to be fluid-tight to a hose system of the heat exchanger.
Abstract: The invention includes three flushing channels each having a flushing channel longitudinal axis oriented parallel to the rotary shaft, which are distributed evenly around a rotary shaft with each flushing channels including a flushing channel cross-section oriented orthogonally to the rotary shaft. The cross-sections are each kidney-shaped and surround the rotary shaft in sectors.
Abstract: The invention relates to a fluid analysis module that comprises for blood analysis: a module housing with a fluid inlet port; at least one fluid sensor that is integrated within the module housing and comprises a sensor surface that is able to make a fluidic connection with the fluid inlet port; a chamber integrated within the module housing. The chamber can be brought into a fluidic connection with the sensor surface of the at least one fluid sensor.
Type:
Grant
Filed:
July 4, 2018
Date of Patent:
December 27, 2022
Assignee:
RESUSCITEC GMBH
Inventors:
Christoph Benk, Juergen Grudke, Rainer Feldbruegge, Michael Borchardt
Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
Abstract: The present invention relates to a protective solution for preventing or reducing reperfusion injury of the brain which contains magnesium ions and which has an osmolality of 350 to 600 mOsm/L, a pH value of 6.8 to 7.8 and albumin in an amount of 1 to 20% by weight.
Type:
Grant
Filed:
May 19, 2020
Date of Patent:
November 30, 2021
Assignee:
ResuSciTec GmbH
Inventors:
Christoph Benk, Friedhelm Beyersdorf, Georg Trummer
Abstract: The present invention relates to a protective solution for preventing or reducing reperfusion injury of the brain which contains magnesium ions and which has an osmolality of 350 to 600 mOsm/L, a pH value of 6.8 to 7.8 and albumin in an amount of 1 to 20% by weight.
Type:
Grant
Filed:
July 1, 2014
Date of Patent:
June 30, 2020
Assignee:
ResuSciTec GmbH
Inventors:
Christoph Benk, Friedhelm Beyersdorf, Georg Trummer
Abstract: The invention relates to a container in the form of a bag having a flexible bag wall at least in a region, in which a first and a second hollow channel section, pass through the bag wall in a fluid-tight manner, wherein the hollow channel sections respectively have an open channel end that is located within the container for connecting the open channel ends to one another in a separable and fluid-tight manner.
Type:
Grant
Filed:
October 1, 2015
Date of Patent:
March 31, 2020
Assignee:
RESUSCITEC GMBH
Inventors:
Christoph Benk, Jürgen Grudke, Joel Louoba
Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).
Abstract: The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).